Baader Bank Aktiengesellschaft’s PHAXIAM Therapeutics S.A.. American Depositary Shares PHXM Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio PHXM Stock Details PHXM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,400	Closed	-$14.7K	–	491
2023 Q2	$14.7K	Buy	+2,400	New	+$21.1K	﹤0.01%	373

Other funds holding PHXM

ADL

Asset Dedication LLC San Francisco, California $1.43B AUM 22.07% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Baader Bank Aktiengesellschaft's PHXM Position: Q3 2023 in Review

Baader Bank Aktiengesellschaft sold out of PHAXIAM Therapeutics S.A.. American Depositary Shares (PHXM) in Q3 2023, closing a stake of 2,400 shares — an estimated $14.7K sold.

Baader Bank Aktiengesellschaft first reported a position in PHXM in Q2 2023 and held it in 1 quarter. The position peaked at $14.7K in Q2 2023. 3 funds tracked by Wall St. Rank hold PHXM as of Q3 2023.

Baader Bank Aktiengesellschaft reported no remaining PHAXIAM Therapeutics S.A.. American Depositary Shares position as of Q3 2023 after selling out during the quarter.
Baader Bank Aktiengesellschaft sold 2,400 PHAXIAM Therapeutics S.A.. American Depositary Shares shares in Q3 2023, an estimated $14.7K.
Baader Bank Aktiengesellschaft first reported a position in PHAXIAM Therapeutics S.A.. American Depositary Shares in Q2 2023 and held it in 1 quarter.
Baader Bank Aktiengesellschaft's PHAXIAM Therapeutics S.A.. American Depositary Shares position peaked at $14.7K in Q2 2023.
3 funds tracked by Wall St. Rank held PHAXIAM Therapeutics S.A.. American Depositary Shares as of Q3 2023.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q3 2023, filed 14 Nov 2023.